Unreported / Non-Citable
Background
Jill Finkelstein sought disability insurance benefits based on degenerative disc disease, bilateral carpal tunnel syndrome, and diabetes with mononeuropathy in both feet. An administrative law judge denied her claim, finding that she retained the residual functional capacity for light work and could perform her past work as a special-education director.
An earlier federal-court remand had requested development of the record through clarification of relevant illegible medical records, particularly handwritten treatment notes from neurologist Dr. Brahmananda Yadlapalli. On remand, the ALJ sent interrogatories and portions of the record to several medical experts, but their responses did not decipher or clarify the neurologist’s notes. The ALJ nevertheless relied on those notes when assessing Finkelstein’s functional capacity.
The Court’s Holding
The court reversed the Commissioner’s decision and remanded under sentence four of 42 U.S.C. § 405(g). It held that the ALJ failed to develop the record fully and fairly because the steps taken after the earlier remand did not clarify Dr. Yadlapalli’s illegible neurological treatment notes.
The error was prejudicial because clarification could have produced additional evidence leading to a different determination of Finkelstein’s residual functional capacity and ability to perform her past work. The court instructed the Commissioner on remand to subpoena Dr. Yadlapalli for clarification and, if he does not comply, to explore another method such as consulting a handwriting expert. Because this issue required remand, the court did not address Finkelstein’s separate argument that the ALJ omitted limitations from medical opinions he had found persuasive.
Key Takeaways
- Sending illegible treatment notes to other physicians did not satisfy the duty to clarify records central to the disability determination.
- The ALJ’s reliance on the illegible notes was harmful because their clarification might have changed the residual-functional-capacity analysis and step-four finding.
- The Commissioner must seek clarification directly from the treating neurologist by subpoena or pursue a reasonable alternative if the neurologist does not comply.
Why It Matters
The decision underscores that an ALJ must meaningfully address material gaps or ambiguities in the medical record, especially after a prior remand specifically identifies them. Additional expert review is insufficient when it leaves the critical evidence unreadable and unexplained.
The court also urged the Commissioner to prioritize the case, noting that Finkelstein’s benefits proceedings had already continued for more than a decade.